# Dirk Arnold

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/dirk-arnold/

## Facts

| Field | Value |
| --- | --- |
| Citations | 34,035 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 64 |
| i10-index | 171 |
| Last Known Institution | Asklepios Klinik Altona |
| OpenAlex ID | https://openalex.org/A5015232096 |
| ORCID iD | https://orcid.org/0000-0002-5325-8182 |
| Works | 483 |

## Researcher papers

- [Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study](https://scholariq.org/papers/fruquintinib-versus-placebo-in-patients-with-refractory-metastatic-colorectal/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Colorectal Cancer Surgical Treatments](https://scholariq.org/topics/colorectal-cancer-surgical-treatments/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Researcher university

- [Asklepios Klinik Altona](https://scholariq.org/institutions/asklepios-klinik-altona/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.